期刊文献+

浙江省耐药结核分枝杆菌katG、rpoB、embB基因突变特点研究 被引量:14

Study on The Characteristics of Mutations on Mycobacterium Tuberculosis katG、rpoB、embB Gene in Zhejiang Province
下载PDF
导出
摘要 目的了解浙江省耐异烟肼、利福平、乙胺丁醇结核分枝杆菌katG、rpoB、embB基因突变特点。方法以结核分枝杆菌标准株H37RV为对照,应用聚合酶链反应——单链构象多态性(PCR-SSCP)技术、聚合酶链反应——直接测序(PCR-DS)技术检测100株耐药结核分枝杆菌临床分离株katG、rpoB、embB基因。结果经PCR-DS检测katG基因突变率达54.8%,以Ser315Thr突变最常见(40.3%);在耐利福平菌株中,rpoB基因突变率达88.9%,以526、531位氨基酸改变最常见,总突变率达77.8%(63/81);在耐乙胺丁醇菌株中,embB基因突变率达60%,以Met306VaI改变最常见(28.9%)。结论PCR-SSCP技术操作简单、检测快速,可作为临床耐药检测的辅助手段;浙江省结核菌耐药基因突变位点同国内研究基本一致,各位点突变形式所占比例有自身特点。 Objective To elucidate the characteristics of katG, rpoB and embB mutations of mycobacterium tuberculosis in Zhejiang province. Methods Compared with the standard strain H37RV, 100 drug - resistant strains were detected by PCR - SSCP and analyzed by direct sequencing technique. Results The mutation rate of katG is 54.8% and the most familiar site is 315 (Ser→Thr) ;88.9% rifampin resistant strains were detect to have mutations, which mainly located at 526 site and 531 site; in the ethambutol resistant strains, the mutation rate is 60% , in which the form of Met306VaI is 28.9%. Conclusions PCR - SSCP technology is a rapid and easy method to detect gene mutations and it could be used to estimate the drug resistance accessorily. The mutation sites of drug resistance strains correspond with current studies conducted in our country, but the proportion of each mutation form has our own characteristics in the study.
出处 《医学研究杂志》 2008年第3期26-29,共4页 Journal of Medical Research
基金 浙江省杭州市科技局资助项目(2005633Q10)
关键词 结核分枝杆菌 耐药 聚合酶链反应-单链构象多态性 序列分析 Mycobacterium tuberculosis Drug resistance PCR -single -strand conformation polymorphism Sequence analysis
  • 相关文献

参考文献7

二级参考文献56

  • 1乐军,曾而良,谢建平,李瑶,梁莉,王洪海.中国耐多药结核分枝杆菌临床分离株rpoB基因突变特点[J].Acta Genetica Sinica,2004,31(12):1332-1336. 被引量:23
  • 2Espinal M A,Laszlo A,Simonsen L,Boulahbal F,Kim S J,Reniero A,Hoffner S,Rieder H L,Binkin N,Dye C,Williams R,Raviglione M C.Global trends in resistance to antituberculosis drugs.N Engl J Med,2001,344(17):1294~1303.
  • 3Dye C,Williams B G,Espinal M A,Raviglione M C.Erasing the world's slow stain: strategies to beat multidrug-resistant tuberculosis.Science,2002,295(5562):2042~2046.
  • 4Becerra M C,Bayona J,Freeman J,Farmer P E,Kim J Y.Redefining MDR-TB transmission-drug resistance'hot spots'.Int J Tuberc Lung Dis,2000,4(5): 387~394.
  • 5Dye C,Scheele S,Dolin P,Pathania V,Raviglione M C.Consensus statement.Global burden of tuberculosis: estimated incidence,prevalence,and mortality by country.WHO Global Surveillance and Monitoring Project.JAMA,1999,18:677~686.
  • 6Dye C,Williams B G.Criteria for the control of drug-resistant tuberculosis.Proc Natl Acad Sci USA,2000,97(14):8180~8185.
  • 7Drobniewski F A,Wilson S M.The rapid diagnosis of isoniazid and rifampin resistance in Mycobacterium tuberculosis--a molecular story.J Med Microbiol,1998,47(3): 189~196.
  • 8Ramaswamy S,Musser J M.Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis:1998 update.Tuberc Lung Dis,1998,79:3~29.
  • 9Hirano K,Abe C,Takahashi M.Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay.J Clin Microbiol,1999,37(8):2663~2666.
  • 10Kapur V,Li L L,Iordanescu S,Hamrick M R,Wanger A,Kreiswirth B N,Musser J M.Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas.J Clin Microbiol,1994,32(4):1095~1098.

共引文献161

同被引文献112

引证文献14

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部